EFTA02454282.pdf
PDF Source (No Download)
Extracted Text (OCR)
From:
jeffrey E. <jeevacation@gmail.com>
Sent:
Friday, August 5, 2016 3:54 PM
To:
Ens, Amanda; Richard Kahn
Subject:
Re: MEGA Action: Post NFP Trades: Hedge US Credit, Buy Financials, Buy USD proxies,
Buy Biotech
amanda lets talk today
On Fri, Aug 5, 2016 at 10:01 AM= Ens, Amanda
> wrote:
The Tai= Hedge: Buy Puts on IG Credit. A Dec LQD 98% Put ($120.00) costs 1.29% ($1=55, ref: $122.80, 7.6 vol, 38 delta)
or sell JGBs.
<=mg src="cid:1585976186" alt="cid:38917479" height="72" width="691"=
MEGA Action: Strong US pa=roll data risks steepening of US yield curve - tail hedge US credit exposu=es.
<=>
Post Strong US Payroll Data we still see a December=US rate hike.
*
=/span>Growing hike expectations will steepening=the US and Japan yield curves. The question is how do Risk
Parity funds ha=dle "The Great Rotation" as US equities continue to look m=re attractive than Fixed Income?
*
=C2* Financials and Health=are and Technology to outperform Utilities and Staples.
=C2* =C2*
USD should also benefit as the US yield curve steepens.
=C2*
There is a chart pack below.
<=>What is the Trade?
1. The Tail Hedge:=Buy Puts on IG Credit. A Dec LQD 98% Put ($120.00) costs 1.29% ($1.55, ref= $122.80, 7.6 vol, 38
delta) or sell JGBs.
EFTA_R1_01555923
EFTA02454282
2.=span style="font:7.0pt "Times New Roman""> <=span>Financials =utperformance: Buy Regional Banks Call. A Dec
KRE, 103% Call ($42) costs 3=8% ($1.60, ref: $41.65, 23.0 vol, 36 delta)
<= style="line-height:150%">3.
=Or=buy a 6M ATM worst-of {XLF (financials) call, XLU (utilities) put} f=r `1.38%(65%
discount to the average vanilla option)
apan style="font-size:10.0pt;line-height:150%;font-family:"Verdana&q=ot,"sans-serif"">4. =span>Post earnings —
Buy Healthca=e & Biotech on improved outlook: Buy Calls on Bio-Tech Index. A Dec 10=% ($310) IBB Call costs $12.70
(4.1%, ref $296.00, 26.0 vol, 41 delta)<=u>
=b>5. =/u>USD Strength Trade: Short the BA=L "Weak USD Winners Equity Custom Basket", MLDIUSDC Index.ru>
=/u>
Rationale
=span style="font-size:10.0pt;font-family:"Verdana","sans-=erir">US Payroll data was a very strong report showing that
the econ=my can resume a higher trajectory of growth into the second half of the ye=r and the Fed can deliver a hike in
December.
=p class="MsoNormal">1) NFP was up 255K with net positive re=isions of 18K. The 6month moving average of 189K
suggests a solid pace of =rowth.
2) Hou=ehold jobs surged 420K, reversing the recent few months of weakness. This =ffset the increase in the labor force
participation to 62.8 from 62.7%, wh=ch is an encouraging sign for the longer run trajectory of job growth. =/u>
3) Average hourly=earnings increased 0.3%, leaving the yoy rate unchanged at 2.6%, showing t=at wages are sticking at a
higher pace.
4) The Unemployment rate held at 4.9% while the=underemployment rate (U6) increased to 9.7%.
5) Professional & business services saw =he strongest job growth of 70,000, though this sector tends to account for=a
good portion of job growth generally. Only mining and logging (-7k) and =nformation services (Ok) were weak.
Post Q2 earnings results, Health =are is now in a strong position to outperform <http://rsch.baml.com/r?q=--
f=Kv0H2hhlw6fcYbuRtA&e=jeevacation%40gmail.com&h=7Ws4Wg> . The sector saw more positive than negative
revisions to estimat=s on a three-month basis, more positive than negative revisions to sales f=recasts and management
has been most positive in guidance.4=pan>
The N=sdaq Biotechnology Index (NBI) has surpassed S&P500 (up 13% vs.=5%) since the end of 1Q, thanks to increased
M&A activity and solid 2Q=earnings reported by the large-cap biotech companies as a group
<http://=sch.baml.com/r?q=DcR3HEJAJ9GrI8M4aKdamg&e=jeevacation%40gmail.com&=mp;h=oE91Sw> =/span>.
Recent NBI rally suggests a "real" =urn in market sentiment post major sector sell-off beginning last August. =2% of S&P
500 companies have beaten on EPS, 52% have beaten on sales a=d 40% have beaten on both compared to full-quarter
historical averages of =3%, 57% and 35%, respectively.
2
EFTA_R1_01555924
EFTA02454283
"Global Equity=Volatility Insights
<http:firs=h.baml.com/r?q=6CfeDcIMVw2r18M4aKdamg&e=jeevacation%.40gmail.com&am=;h=1H7UoA> " from June
28 and su=gests risk parity fund leverage is high and we do not think the relationsh=ps have changed significantly. As
correlation between bonds and SPX increa=es, risk parity leverage increases.
The Bank of Japan's "=comprehensive assessment" in Sep MPM is creating intense speculation<=span>
chttp://rsch.baml.com/r?q=Qnr=±5ChBkWri8M4aKdamg&e=jeevacation%40gmail.com&h=Hiu8QQ> . BoJ may make
QQE more flexible whic= would enhance policy sustainability risking steeper yield curve, stronger=yen and weaker
equity but bank shares to rise. If the BoJ does move to mak= policy more flexible, we think the focus will be on JGBs,
rather than on =egative interest rates.
Chart Pack:
Nasdaq Bio Tech Index: Buy Calls on Bio-Tech=b>
In JGB Futures, 150.60 is an impor=ant level for all global fixed income.
<=span>
Regional Bank ETF (KRE): Buy Calls on KRE=span style="font-size:10.0pt;font-family:"Verdana","sans-=erif—>
Short the BAML "Weak USD Winne=s Equity Custom Basket"
<=span>
This chart is a danger for risk parity funds as bond/equity correlation swings positive.<=span>
=span style="font-size:10.0ptfont-family:"Verdana","sans-=erif- >
3
EFTA_R1_01555925
EFTA02454284
=p class="MsoNormal">Greg Kaldor=span style="font-size:10.0pt;font-family:"Verdana","sans-=erif";color:#948671">
Managing Director
Us MEGA (Macro Equity & Global Alpha)
Bank of America Merrill L nch
T+
B/Berry
This message, and any attachments, is for the intended rec=pient(s) only, may contain information that is privileged,
confidential an=/or proprietary and subject to important terms and conditions available at=emaildisclaimer
<http://www.bankofamerica.com/emaildisclaimen . If you are not the =ntended recipient, please delete this message.
</=iv>
2046442
This message, and any attachments, is for the intended reci=ient(s) only, may contain information that is privileged,
confidential and=or proprietary and subject to important terms and conditions available at =a
href="http://www.bankofamerica.com/emaildisclaimer"
target="_blank">=ttp://www.bankofamerica.com/emaildisdaimer. If you are not the i=tended recipient, please delete
this message.
<http://rsch-bems-
tr. baml.com/q/k JsMBs9lnliqHZexGTRCQ--/AAAAAQA4RgRZhyCoPkEIA0vEkF4AsNhCCgADqJukV5ii4BNSFWpIZXZhY2
F0aW9uQGdtYWIslmNybalRB=AAAABFImXsibmFtZSI6IjA4MDUxMDAxODY4MzI4ODE6MjA0NjQ3NillTkEwliwiYXV0aG9yl
GVt=WIsljoiYWRtaW5AY29sZHNwYX.IrlmNvbSIsImNsaWVudF9pZCI6ljUtM DgwNTEwM DE4NjgzMjg=MToyMDQ2NDc2LU
hOQTAiLCJ0ZW1wbGE0ZSI6ImRIZmElbH RfdGVtcGxhdG
2046476
4
EFTA_R1_01555926
EFTA02454285
=AO please note
The information contained i= this communication is
confidential, may be attorney-client privileged,=may
constitute inside information, and is intended only for
the use =f the addressee. It is the property of
JEE
Unauthorized use, disclos=re or copying of this
communication or any part thereof is strictly pro=ibited
and may be unlawful. If you have received this
communication =n error, please notify us immediately by
return e-mail or by e-mail to =a href="mailto:jeevacation@gmail.com" target="_blank">jeevacation@gmai=.com, and
destroy this communication and all copies thereof,
inc=uding all attachments. copyright -all rights reserved
5
EFTA_R1_01555927
EFTA02454286
Document Preview
PDF source document
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
Extracted Information
Email Addresses
Phone Numbers
Document Details
| Filename | EFTA02454282.pdf |
| File Size | 359.5 KB |
| OCR Confidence | 85.0% |
| Has Readable Text | Yes |
| Text Length | 7,543 characters |
| Indexed | 2026-02-12T17:31:10.348081 |